Optellum
Edit

Optellum

http://www.optellum.com/
Last activity: 13.08.2026
Active
Categories: AIHealthcareLungCancerMedicalDeviceSoftware
Optellum was founded so that every lung cancer patient is treated at the earliest possible stage, and cured. We are redefining early interception of lung disease, by enabling every clinician, in every hospital, to manage their patients in the optimal way.

Our first product is the first Clinical Decision Support software for personalized early diagnosis & treatment of lung cancer, based on Artificial Intelligence & Machine Learning applied to the world’s largest clinical dataset.

We are a team of world-leading medical imaging software, AI, and clinical experts who met at Oxford’s world-renowned computer vision laboratory. Between us, we have track records of bringing innovation to market through over 10 start-up companies, resulting already in 5 trade-sales and one IPO.

We are backed by an Advisory Board comprising world-leading clinicians (global authors of medical guidelines) and experts in deep learning.

We are building up our development team – join our fight against cancer, working together with former software engineers from top technology companies (Amazon, Facebook, Redhat) and veterans of medical imaging startups.

Learn more at http://www.optellum.com/.
Followers
306
Mentions
103
Location: United Kingdom
Employees: 11-50
Total raised: $15.25M
Founded date: 2016

Investors 4

Funding Rounds 2

DateSeriesAmountInvestors
11.10.2022Series A$14M-
15.07.2019-$1.25MLuminous V...

Mentions in press and media 103

DateTitleDescription
13.08.2026Coreline Soft and Optellum announce intent to collaborate to advance AI across the lung cancer pathwayProposed collaboration would make Coreline Soft's FDA-cleared lung nodule detection capability available through Optellum's LungOS® platform OXFORD, England and SEOUL, South Korea, Aug. 13, 2026 /PRNewswire/ -- Optellum and Coreline Soft to...
05.06.2026Optellum Celebrates Accelerating Impact in Lung Cancer Care; Now at Over 250 Sites and GrowingOXFORD, United Kingdom and HOUSTON, June 5, 2026 /PRNewswire/ -- Optellum, a leader in AI-enabled lung cancer diagnostics, today announced that it has surpassed 250 clinical sites and analyzed more than 3 million cases to date. This milesto...
03.06.2026Massive Bio & Optellum Collaborate to Accelerate Clinical Trial Access for Early-Stage NSCLC PatientsMassive Bio and Optellum are joining forces to streamline clinical trial matching for early-stage non-small cell lung cancer patients through AI-driven precision oncology. Lung cancer risk detection meets precision trial matching, connectin...
27.02.2026Optellum Secures TGA Approval to Expand AI-Enabled Lung Nodule Solution To AustraliaOXFORD, England, Feb. 27, 2026 /PRNewswire/ -- Optellum, the leading AI-enabled solution for earlier lung cancer detection, is thrilled to announce that it has received Therapeutic Goods Administration (TGA) class IIb approval in Australia ...
17.10.2023ConcertAI’s TeraRecon Integrates AI-Powered Early Lung Cancer Diagnosis With OptellumConcertAI’s TeraRecon, the advanced visualization and clinical AI SaaS company, announced its strategic collaboration with Optellum Ltd (Oxford, UK), a global leader in AI clinical decision support for early lung cancer diagnosis and precis...
14.12.2022Houston innovator gears up for commercialization for AI-driven lung cancer diagnostic toolWhen a United Kingdom-based, artificial intelligence-driven lung cancer detection tool opened its United States headquarters in Houston, the company tasked Jason Pesterfield with the role of CEO to oversee international expansion and commer...
09.11.2022Houston founder grows B2B SaaS platform that's supporting the neurodiverse workforceMuch of the workforce — and humanity in general – is neurodiverse, and the business world doesn't factor in cognitive differences into the workplace like it should in order to support employees of all learning abilities. Betsy Furler wanted...
26.10.2022Here's which of the 2022 Houston Innovation Awards finalists are hiringAfter scouring Houston for the best of the Houston innovation ecosystem and evaluating dozens of companies, InnovationMap and Houston Exponential have announced the finalists that will be honored at the 2022 Houston Innovation Awards. But w...
24.10.2022Early-stage startup accelerator names latest Houston cohortThe sixth Houston cohort for global startup accelerator and investor gener8tor's gBETA program is underway, and five Houston early-stage companies have joined the program. The no-equity program, which is based out of the Downtown Launchpad,...
20.10.20226 startups join Houston sports tech programA Houston-based organization focused on advancing sports tech startups has named its latest cohort. Pokatok Labs announced the addition of six companies to its portfolio as the program — focused on seed and series A startups across health t...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In